Imaging Flashcards
(132 cards)
Question 20
A 54-year-old woman with lupus is hypoxaemic in a Durban intensive care unit after abdominal surgery. She is supported on the following ventilatory parameters
Calculate the alveolar-arterial gradient, D(A-a)O2, and give 2 possible causes of hypoxaemia
in the above patient. What is the limitation of this equation? (5)
This patient has a high A-a gradient which could be secondary to ventilation defect vq mismatch or perfusion defect shunting of blood
PAO2= FiO2 (PB-SVH20)-PaCO2/R+F
Norma gradient <20mmhg(<2.7KPA)
Hg A-a gradient = VQ mismatch or diffusion abnormality
Normal gradient with hypoxia = hypercarbia
A 67 year old man is scheduled for repair of his inguinal hernia. On closer questioning he reviled history of haemoptysis,. Hi P CXR is shown.
1. Describe the xray
2. What is the underlying diagnosis
Diagnosis: COPD
Features:
° Hyperinflation a flat diaphragms , there should be 7 intercostals spaces seen
° Horizontal orientation of ribs
° osteopenic ribs 2° chronic steroid use
What does above image
show?
The image shows a large right-sided pneumothorax with visible margins of the collapsed lung. Pneumothorax is the presence of gas within the pleural space owing to disruption of the parietal or visceral pleura
How do you treat tension pneumothorax?
○ Tension pneumothorax is a surgical emergency, and if suspected on clinical grounds, time should not be spent seeking radiological evidence.
○ A large-bore needle should be placed in the second intercostal space in the midclavicular line, allowing air to drain freely (Fig. 44.3).
○ The needle should be left in place until a tube thoracotomy is performed.
What are the indications for surgical intervention for a pneumothorax?
An air leak from the lung that persists for more than 10days may be an indication for surgical intervention. Recurrent pneumothorax can be treated by chemical pleurodesis without a thoracotomy by instilling tetracycline into the pleural space [3].
Is there a way to classify this condition (pneumothorax)?
Classification Neonatal, spontaneous, traumatic
• Pediatric pneumothorax– neonates with respiratory distress syndrome, especially if they are mechanically ventilated with positive and expiratory pressure and are prone to pneumothorax.
• Congenital diaphragmatic hernia results in underdeveloped lung ipsilateral to the defect in diaphragm. The more compliant contralateral lung is prone to barotrauma and pneumothorax.
○ Spontaneous pneumothorax occurs without trauma and most often in males between 20 and 35years of age. These patients are often tall and slender, and most of the patients are smokers. Recurrent spontaneous pneumothorax is common during the first year after the initial event. Primary spontaneous pneumothorax occurs in tall, thin males aged 20–40 and who are smokers. Secondary spontaneous pneumothorax occurs in patients with underlying pulmonary disease, and the presentation may be more serious with symptoms and sequelae due to comorbid conditions. ○ Traumatic pneumothorax Blunt or penetrating trauma to the chest wall can cause a pneumothorax; the most common cause is iatrogenic and is caused by subclavian line placement. ○ Tension pneumothorax This occurs when air enters the pleural cavity on inspiration but, because of a ball-valve mechanism, is unable to exit. This progressively enlarges the pleural space, shifting the mediastinum and trachea to the contralateral side and also decreasing venous return.
○ Tension pneumothorax is a medical emergency and without prompt intervention leads to rapid deterioration in the patient’s condition leading to death [1].
Name some causes for the changes seen in the image?
What’s the most valuable x-ray finding used to help differentiate the etiology of this finding
The most common causes of unilateral lung whiteout on chest radiograph (Fig. 45.1) are pneumonia, pleural effusion (including hemothorax), and collapse/atelectasis. The ability to differentiate between collapse and pleural effusion is essential beca
2. The most important finding that may help differentiate the etiology of unilateral whiteout is tracheal deviation or mediastinal shiftuse they require distinct treatments, which, if applied erroneously, could harm the patient [1].
What is the differential diagnosis of this finding when there is no tracheal deviation or mediastinal shift on chest x-ray?
○ With a finding of central mediastinum, diagnostic considerations include consolidation/pneumonia, pulmonary edema/ARDS, small to moderate pleural effusions (most likely would cause a partial rather than a complete whiteout), and mesothelioma. ○ Small and moderate pleural effusions tend to gravitate posteriorly without producing mediastinal shift.
○ Encasement of the lung in a mesothelioma patient limits mediastinal shift.
What is the differential diagnosis when there is mediastinal shift away from the opacity?
○ With tracheal displacement away from the diffuse opacity, diagnostic considerations include a moderate to large pleural effusion, large pulmonary mass, and a diaphragmatic hernia.
○ Diaphragmatic hernias on the right side usually consist of liver herniation, while on the left, from herniated bowel.
What is the differential diagnosis when there is mediastinal shift toward the opacity?
Mediastinal shift toward the side of the opacity is seen in lung collapse (endobronchial intubation, mucus plugging), post-pneumonectomy, and pulmonary agenesis/hypoplasia. The figure above (Fig. 45.1) illustrates a case of mucus plugging in the ICU in a young patient with high-level spinal cord injury compromising the strength of his cough and therefore his ability to clear secretions. This scenario can be encountered by the anesthesiologist quite often. Endotracheal tube repositioning with or without bronchoscopy is a simple fix to main stem intubation, whereas endotracheal suctioning or bronchoscopy are easily performed to clear secretions and/or mucus plugs [1, 2, 3].
A 65-year-old female after a motor vehicle collision requires emergency surgery for an open lower extremity fracture; the patient tells you she has a “bad heart,” she has no history in your institution, and no signs of heart failure. An EKG shows wide QRS with dual-chamber pacing. A CXR on admission show (See Fig.46.1). 1. What type of device is shown in the image?
This patient has an implantable biventricular cardio-defibrillator (BiV ICD) [1].
(a) The radiographic image of a pacemaker would show (See Fig.46.2):
• Smaller generator
• Discreet right ventricular lead (stable diameter)
• With or without right atrial lead or coronary sinus lead
(b) The radiographic image of an ICD would show above image:
• Larger generator.
• Prominent right ventricular lead, otherwise known as shock coils.
They appear as two metallic segments along the length of the ICD lead.
(c) The radiographic image of a BiV ICD would show (See Fig.46.4):
• Larger generator
• Prominent right ventricular lead (shock coils)
• Right atrium lead
• Coronary sinus lead
Manufacturer ID can be seen in the CXR as well
What are the indications for cardiac implantable electronic device placement?
Indications for cardiac implantable electronic device placement [2]:
(a) Pacemaker:
• Patients with symptomatic sinus node dysfunction and bradycardia
• Patients with complete AV block (symptoms less relevant)
• Hypersensitive carotid sinus syndrome and neurocardiogenic syncope
(b)ICD:
• Patients at risk of sudden cardiac death: Prior ventricular tachycardia or fibrillation, low ejection fraction [3]
• Long QT syndrome
• Hypertrophic cardiomyopathy
• Arrhythmogenic right ventricular dysplasia • Cardiac transplantation
•Primary electrical disease: idiopathic ventricular fibrillation, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia
(c) BiV ICD:
• Treatment of left ventricular dysfunction and heart failure, with prolonged ventricular conduction and heart failure symptoms.
• Required ventricular pacing and low EF:– RV pacing in patients with low EF increases CHF admissions and mortality. • Cardiac resynchronization therapy [4]:– Improved exercise tolerance and mortality.– Continuous pacing provides better hemodynamic stability.
What is the effect of placing a magnet over the device (pacemaker and/or ICD)?
Chapter 38 millers
○ Effect of a magnet on a device [5]: depends on manufacturer type and whether the magnet application is turned on. ST Jude vs Meditronic
(a) Pacemaker:
• Suspend sensing of intrinsic rhythm.
• Pacing in an asynchronous mode: the rate depends on the manufacturer and the battery life; if the battery life is low, the rate may not be adequate for surgery.
• Turns off “rate response.”
(b)ICD:
• Varies depending on device, manufacturer, and programming of the device.
• In general it turns off detection of tachycardia and tachycardia therapy (discharge and pacing).
• In general, it has no effect on the pacemaker (pacing will not become asynchronous). In patients that are pacemaker dependent due to the risk of electrical interference and pacemaker malfunction, it is best to reprogram the device to address both the tachycardia and bradycardia therapy.
In the OR, you place a magnet over the device. The patient goes pulseless after prolonged use of electrocautery. What is your diagnosis?
○ Most probably this patient has a BiV ICD and low ejection fraction and is pacemaker dependent.
° The device functioned appropriately with the magnet, which suspended the tachyarrhythmia detection.
° Pacing was inhibited by the prolonged use of electrocautery.
° Pacing returns to an unresponsive myocardium, after a prolonged period of asystole that might have led to PEA arrest.
What are the effects of electrocautery, radiation therapy, and radiofrequency on a pacemaker and an ICD?
Pacemaker [1, 6]:
(a) Electrocautery:
• Faulty sensing of intrinsic activity causing inappropriate inhibition of pacemaker activity– More prominent with monopolar cautery– More likely with above the waist surgery
• Possible device reset or damage to the generator, or the leads, but unlikely
(b)Radiation therapy:
• Possible device reset when performed near the device
(c) Radiofrequency:
• Electrocautery-like electromagnetic interference that could cause inappropriate inhibition of pacemaker activity which is more likely with procedures above the waist • Possible device reset or damage to the generator, or the leads, but unlikely
ICD:
(a) Electrocautery:
• Faulty sensing of intrinsic activity causing inappropriate sensing of arrhythmias– More prominent with monopolar cautery • Possible device reset or damage to the generator, or the leads, but unlikely (b)Radiation therapy:
• Possible device reset when performed near the device
(c) Radiofrequency:
• Electrocautery-like electromagnetic interference that could cause inappropriate arrhythmia sensing inhibition
• Possible device reset or damage to the generator, or the leads, but unlikely
What measures can you take to ensure proper intraoperative device functioning? Pacemaker
When facing a patient with a device one must ascertain [1, 5]: 243 46 CXR III
(a) Device type and obtain as much information as possible
• Is there a history of cardiac arrest, arrhythmias, or VT/VF?
• Evaluate medical record, registration card.
• Contact the manufacturer.
(b) Procedure type: Location and presence of electromagnetic interference
(c) Patients characteristics:
• Pacemaker dependence:– Usually can tell just from the monitor or EKG.If pacing spikes are not visible, then usually they are not dependent.– If there are spikes in front of all or most P waves and/or QRS complexes, then assume pacemaker dependency.
• Chambers being paced
• Presence of low EF? (d) Urgency of the case
• Elective cases:– Contact patient’s provider, pacemakers should be seen every year, and ICDs every 6 months.– Follow recommendations.
• Emergency cases:
(1) General recommendations:
a. Have magnet immediately available.
i. If magnet impossible to place, must call EP; the device might require reprograming before the procedure.
b. Monitor patient with plethysmography or arterial line.
i. All other forms of monitoring are unreliable due to noise with electromagnetic interference.
c. Transcutaneous pacing and defibrillation pads should be placed (anterior/posterior).
d. Evaluate the pacemaker or ICD before leaving a cardiac-monitored environment.
e. ICD patients should be on monitor at all times while ICD is deactivated.
f. If any device is programmed specifically for surgery, patient cannot be taken off the monitor until the device is reprogrammed. (2)
○ Recommendations for patients—not pacemaker dependent
a. No ICD present:
i. If the surgery is not within 6 inches (15cm) of the device, then no other actions are necessary.
ii. If the surgery is within 6 inches of the device, then a magnet can be placed or the device reprogramed by a device specialist to asynchronous mode (AOO, VOO, DOO).
b. ICD or BiV ICD present:
i. Place magnet to stop tachyarrhythmia detection.
ii. If magnet is impossible to place, or surgery is within 6inches of the device, or is a cardiac/thoracic procedure, then you must call the device specialist to turn off the tachyarrhythmia detection to avoid unwarranted discharges during the procedure if electrical interference is present.
(3) Recommendations for patients—pacemaker dependent
a. No ICD present:
i. Use short electrosurgical bursts.
ii. Place magnet over device for procedures not within 6 inches (15cm) of the device.
iii. If magnet is impossible to place or surgery is within 6 inches of the device, then the device specialists must be called to reprogram to an asynchronous mode. b. ICD or BiV ICD present:
i. Use short electrosurgical bursts.
ii. If the surgery is not within 6 inches of the device, then place magnet over device to suspend tachyarrhythmia detection and contact the device specialist to reprogram the device to an asynchronous mode.
iii. If magnet is impossible to place or surgery within 6 inches of the device, then contact in-hospital device specialist to reprogram the device to an asynchronous mode to avoid electrical interference and to turn off tachyarrhythmia detection to avoid unwarranted discharges during the procedure.
What do the images above show and what is the differential diagnosis based on the appearance seen in the images above?
○ The chest X-ray (Fig. 47.1) shows diffuse bilateral coalescent opacities, whereas the CT chest (Fig. 47.2) shows ground-glass opacification, reflecting an overall reduction in the air content of the affected lung. It is also possible to visualize bronchial dilatation within areas of ground-glass opacification.
Differential diagnosis include
(a) ARDS,
(b) congestive heart failure,
(c) pulmonary hemorrhage,
(d) pneumonia,(
e) transfusion-related acute lung injury, and
(f) non-cardiogenic pulmonary edema.
What is the current definition of acute respiratory distress syndrome?
○ The Berlin definition, dated 2012, states that acute respiratory distress syndrome is an entity characterized by hypoxemia and stiff lungs that occurs within a week of a known clinical insult or new/worsening respiratory symptoms.
° It presents with bilateral opacities on the chest X-ray involving at least three quadrants that are not fully explained by effusions, atelectasis, or nodules.
° Chest computed tomography (CT) findings are opacification that is denser in the most dependent regions as compared to more normal and hyper-expanded lung in the nondependent ones. In addition, CT chest shows widespread ground-glass attenuation, which is a nonspecific sign that reflects an overall reduction in the air content of the affected lung.
○ Respiratory failure in ARDS must not be fully explained by cardiac failure, and an objective assessment for exclusion of such cause may be necessary by echocardiography.
○ Finally, ARDS is classified as mild, moderate, or severe based on PaO2/ FiO2 ratio and PEEP.
° If PaO2/FiO2 ratio is between 200 and 300mmHg with PEEP ≥5, it is classified as mild.
° If PaO2/FiO2 ratio between 100 and 200mmHg with PEEP ≥5, it is moderate.
° PaO2/FiO2 ratio less than 100mmHg with PEEP ≥5 is classified as severe.
Note that the term acute lung injury has been removed, as well as the requirement of pulmonary capillary wedge pressure ≤18mmHg.
Name some common triggers for the development of ARDS.
Common risk factors for ARDS are divided into two categories: direct and indirect.
(a) Direct causes are pneumonia, aspiration of gastric contents, inhalational injury, pulmonary contusion, pulmonary vasculitis, and drowning.
(b) Indirect causes are non-pulmonary sepsis, major trauma, pancreatitis, severe burns, non-cardiogenic shock, drug overdose, and multiple transfusions or transfusion-associated acute lung injury (TRALI).
What is the approach for mechanical ventilation on patients with the above diagnosis? ARDS
○ Protective lung strategy (also known as open lung approach or lung protective ventilation) is the standard of care for the management of patients with ARDS.
○ The ARDS Network was a randomized controlled trial designed based on the concept that the limitation of end inspiratory lung stretch may reduce mortality in this patient population.
°Patients that received lower tidal volume (Vt 4–6ml/kg ideal body weight) and maintenance of plateau pressure between 25 and 30mmHg had a survival benefit, with a decrease in mortality from 40% to 31%.
°Drawbacks from this mode of ventilation were hypoventilation leading to permissive hypercapnia and shear injury due to repetitive opening and closing of alveoli with each cycle. For that reason, PEEP should be set at above lower inflection point to prevent cyclic atelectasis.
○It is difficult to describe an efficient method of applying optimal PEEP in any given patient.
°Applying the highest PEEP that allows for maintenance of goal plateau pressure could be a reasonable approach.
°In that study, the survival benefit was also associated with a reduction of plasma IL-6, supporting the hypothesis that a lung protective strategy limits the spill of inflammatory mediators into the systemic circulation, which may induce multiple system organ failure.
○In refractory hypoxemia, prolonging the inspiratory time by increasing the I:E ratio may improve oxygenation; however, close attention must be directed to avoid air trapping, auto-PEEP, barotrauma, and hemodynamic compromise
Is there an indication for steroids, statins, or neuromuscular blockade (NMB) in ARDS
○ The use of glucocorticoid treatment for ARDS remains contradictory.
° The ARDS Network LaSRS study showed no benefit in mortality from the routine use of steroids in patients with ARDS.
° In addition, it was associated with increased risk of neuromuscular complications, as well as risk of death if started 2weeks after onset of ARDS.
° The potential adverse effects of steroids also include immunosuppression, superadded infection, and higher blood glucose levels. The mineralocorticoid component contributes to fluid/sodium retention; both of which could result in positive fluid balance, a known factor associated with poor outcomes in lung injury.
***At the moment, there is insufficient evidence to justify the routine use of steroids in patients with ARDS.
○ The SAILS trial published in 2014 compared statin with placebo in patients with ARDS in the setting of sepsis.
° Statin therapy did not reduce mortality or increase ventilator free days; therefore there is no evidence to support its use in ARDS.
○Neuromuscular blockade therapy for hypoxia has a few potential benefits.
° Avoidance of large tidal volumes that predispose to volutrauma decreased oxygen consumption from lack of muscle activity and improved patient–ventilator synchrony.
° Literature shows that the use of NMB in early (first 48h) ARDS is associated with improved mortality rate. Having said that, judicious use is warranted since paralysis interferes with neurological exam and has been linked to ICU-acquired weakness and posttraumatic stress disorder
Which nonconventional therapies can be used to enhance oxygenation in severe ARDS?
- Airway pressure release ventilation (APRV) is a combination of pressure- controlled ventilation and inverted ratio ventilation on a time-triggered, pressure- targeted, and time-cycled mode (Fig. 47.3).
○ A higher and a lower PEEP are set, and 80–95% of the respiratory cycle is spent during inspiration at the higher PEEP.
○The patient is allowed to breathe spontaneously during both high and low PEEP.
○ The mean airway pressure increases without much increase in the peak pressure, favoring lung protection.
○ This mode has been found to be associated with shorter ICU stay and duration of ventilation in patients with ARDS, but contradictory literature still exists, mostly in regard to the lack of evidence of mortality benefit. - High-frequency oscillatory ventilation (HFOV) has been evaluated recently by two randomized controlled trials (OSCAR, and OSCILLATE) as well as by a meta- analysis.
○ HFOV has failed to show any mortality benefit.
○ The HFOV group in the OSCILLATE trial had higher mortality, higher requirement for sedatives, paralytics, and vasopressors, and therefore no evidence to support its use. - Prone positioning takes advantage of gravity and repositioning of the heart in the thorax to recruit lung regions and improve ventilation–perfusion matching.
○ The mechanisms for the proposed benefit are change in diaphragm movements, increased functional and residual capacity, better secretion clearance, and reduced ventilator-induced lung injury.
○ The PROSEVA trial, published in 2013, brought attention back to this rescue mode after showing association with major decrease in 28-day and 90-day mortality, increase in ventilation-free days, and reduced time to extubation. ○ An increase in PaO2 by 10mmHg over the first 30min of prone ventilation usually predicts a sustained increase in PaO2 and deems the patient as a “responder.” - Finally, extracorporeal membrane oxygenation (ECMO) remains an important tool for managing refractory hypoxemia that is life-threatening but often considered as a last resort. Literature on its benefit is scarce and controversial.
○ Guidelines suggest it should be used in scenarios that have a potential reversible cause, less than 7days on mechanical ventilation, age <65years, no significant comorbidities, no contraindication to anticoagulation, and no significant neurological dysfunction. In case of isolated respiratory failure, a veno-venous approach is advised, whereas in case of hemodynamic instability, a venoarterial approach should be used. More evidence is needed to support its use as standard of care [5].
What is the role of nitric oxide and prostaglandins in ARDS?
○ Inhaled vasodilators reduce pulmonary arterial pressure and redistribute blood flow to well-ventilated lung regions with little to no systemic side effects, improving the ventilation–perfusion matching.
○ Inhaled nitric oxide has been shown to improve oxygenation as measured by PaO2/FiO2 ratio and oxygenation index.
○ It is expensive, gets rapidly inactivated by hemoglobin, can result in methemoglobinemia, and carries an increased risk of renal failure.
***No beneficial effect on mortality or ventilator-free days has been shown with the use of nitric oxide.
○ Inhaled prostaglandins demonstrate similar vasodilator effects when compared to nitric oxide, including improved oxygenation and reduction in pulmonary hypertension; however evidence with large randomized clinical trials is lacking.
○ Patients on these vasodilators are considered “responders” if an improvement on oxygenation is observed within the first 1h of administration.
○ Based on current evidence, inhaled vasodilators must be considered only as a rescue and temporary therapy for patients with refractory hypoxemia (with or without pulmonary hypertension) when other methods have failed.
A 58-year-old man with a diagnosis of Hodgkin’s disease presents to the anesthesia preoperative clinic prior to placement of a port. He complains of mild difficulty in sleeping totally supine and clinically shows fullness of the veins of the neck. CT scan (Fig.48.1) shows that he has a mediastinal mass with both tracheal deviation and crescentic compression. 1. What are the symptoms of a mediastinal mass?
- Symptoms of a mediastinal mass:
(a) A mediastinal mass may be asymptomatic even when it reaches a significant size. It may be discovered during routine radiological testing for the disease causing the mass or just incidentally [1].
(b) When the mass reaches a critical size within the restricted mediastinal space, it can cause signs and symptoms related primarily to the cardiac or pulmonary system.
° This can include diminished venous return via the superior vena cava (SVC) leading to fullness of the neck veins and in extreme cases cardiac dysfunction from direct compression.
° Respiratory symptoms could range from dyspnea, progressive orthopnea, voice changes (nerve palsy), and in late stages stridor